Aberdeen Group
AGTC

Aberdeen Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Aberdeen Group’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-21,498
Closed -$80K – 922
2018
Q2 		$80K Buy
+21,498
New +$99.5K ﹤0.01% 897

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Aberdeen Group's AGTC Position: Q3 2018 in Review

Aberdeen Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2018, closing a stake of 21,498 shares — an estimated $80K sold.

Aberdeen Group first reported a position in AGTC in Q2 2018 and held it in 1 quarter. The position peaked at $80K in Q2 2018. 61 funds tracked by Wall St. Rank hold AGTC as of Q3 2018.

  • Aberdeen Group reported no remaining Applied Genetic Technologies Corporation position as of Q3 2018 after selling out during the quarter.
  • Aberdeen Group sold 21,498 Applied Genetic Technologies Corporation shares in Q3 2018, an estimated $80K.
  • Aberdeen Group first reported a position in Applied Genetic Technologies Corporation in Q2 2018 and held it in 1 quarter.
  • Aberdeen Group's Applied Genetic Technologies Corporation position peaked at $80K in Q2 2018.
  • 61 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2018.

Based on Aberdeen Group's 13F filing for Q3 2018, filed 13 Nov 2018.